
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The companys initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The companys present development and clinical efforts are focused on mitral valve repair with the MitraClip system. Evalve obtained CE mark approval in 2008 for the MitraClip system, the worlds first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company
Interventional cardiology
Evalve, inc. [a wholly owned subsidiary of abbott vascular, inc.] operates in the Medical device industry.
Evalve, inc. [a wholly owned subsidiary of abbott vascular, inc.]'s revenue is 11m - 100m
Evalve, inc. [a wholly owned subsidiary of abbott vascular, inc.] has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.